Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market
Benzinga Newsdesk - Dec 6, 2023, 8:08AM